Drug Store News editor in chief Rob Eder sat down with Randy Edeker, chairman, president and CEO of Hy-Vee and recently appointed National Association of Chain Drug Stores chairman, to discuss the current state of retail pharmacy, the big challenges facing the industry, his top priorities as NACDS chairman and the role a regional supermarket pharmacy chain like Hy-Vee can play in innovating health care and being a catalyst for change.
Type-2 diabetes patients do better when a pharmacist is a part of their care team.
The Food and Drug Administration Friday announced that it had approved Rapamune (sirolimus), distributed by Pfizer’s Wyeth Pharmaceuticals, as a treatment for the rare lung disease lymphangioleiomyomatosis (LAM).
Teva on Friday announced that it would be rolling out a generic version of Lomedia 24 Fe birth control bills.
On Thursday Roxane Laboratories announced that its alosetron hydrochloride tablets — a generic version of irritable bowel syndrome treatment Lotronex — was available in 0.5- and 1-mg strength.
Some online pharmacy sites will soon be able to point visitors to their .pharmacy domain names.
Camber Pharmaceuticals on Thursday announced that it had launched antipsychotic drug aripiprazole — a generic version of Abilify — in 2-, 5-, 10-, 15-, 20- and 30-mg dosage strength tablets.
The AARP Public Policy Institute’s latest Rx Price Watch Report shows that, despite an overall 4% decrease in price in 2013, the prices of generic drugs seem to be dropping at the slowest rate since 2006.
HDMA on Thursday named two new VPs representing its government affairs team.
The U.S. Food and Drug Administration approved two treatments for irritable bowel syndrome with diarrhea (IBS-D) on Wednesday.